AMMONIUM LACTATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ammonium Lactate, and what generic alternatives are available?
Ammonium Lactate is a drug marketed by Padagis Israel, Taro, and Watson Labs Inc. and is included in six NDAs.
The generic ingredient in AMMONIUM LACTATE is ammonium lactate. There are forty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ammonium Lactate
A generic version of AMMONIUM LACTATE was approved as ammonium lactate by PADAGIS ISRAEL on May 1st, 2002.
Summary for AMMONIUM LACTATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 6 |
Patent Applications: | 1,288 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AMMONIUM LACTATE |
DailyMed Link: | AMMONIUM LACTATE at DailyMed |
Recent Clinical Trials for AMMONIUM LACTATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Indonesia University | Phase 3 |
University of California, San Francisco | Phase 4 |
Wright State University | Phase 4 |
Pharmacology for AMMONIUM LACTATE
Mechanism of Action | Acidifying Activity |